No Data Yet
Mr. Benjamin Kovler is the Chairman of the Board of Green Thumb Industries Inc, joining the firm since 2014.
The current price of GTBIF is $8.2, it has decreased 0% in the last trading day.
Green Thumb Industries Inc belongs to Pharmaceuticals industry and the sector is Health Care
Green Thumb Industries Inc's current market cap is $1.6B
According to wall street analysts, 11 analysts have made analyst ratings for Green Thumb Industries Inc, including 2 strong buy, 11 buy, 1 hold, 0 sell, and 2 strong sell
Looks like you're keeping an eye on the cannabis sector, anon. Green Thumb Industries (GTBIF) is actually seeing a slight dip today, not a major rally. The stock is caught in a tug-of-war between a recent labor strike putting pressure on the price and a very bullish long-term outlook from analysts who see significant upside.
The current price action for GTBIF is a classic case of short-term negative news clashing with strong underlying fundamentals. Here’s the breakdown:
The Main Drag: Labor Strike The most significant recent event is the Unfair Labor Practice (ULP) strike by Teamsters at a RISE Dispensary, a subsidiary of Green Thumb, in York, Pennsylvania . This kind of labor dispute can create negative sentiment among investors, fearing operational disruptions and increased costs, which is likely the primary reason for the stock's softness today.
Technical Picture: Neutral & Choppy As of today, GTBIF is trading around $7.41, down about 1.2% . The stock is currently pinned between a daily support level at approximately $6.81 and a resistance level at $7.80 . The overall daily technical analysis signal is "neutral," with indicators split between buy, sell, and neutral, confirming the lack of a strong directional trend right now . The price is essentially consolidating as the market digests the conflicting news.
The Bull Case: Strong Analyst Conviction Despite the strike, Wall Street analysts remain overwhelmingly positive on GTBIF. The consensus includes 11 "Buy" and 2 "Strong Buy" ratings, with zero "Sell" ratings . The mean analyst price target sits around $12.50, implying over 65% upside from the current price . One recent analyst report from September 1st even recommended selling a competitor (TerrAscend) to buy Green Thumb, citing its stronger fundamentals and lower risk profile .
Sector Tailwinds The entire cannabis sector has been buoyed by optimism around potential federal rescheduling in the U.S. . This broader narrative provides a strong underlying support for major players like Green Thumb, even when they face company-specific headwinds.
So, while the strike is causing some short-term pain, the bigger picture remains bullish in the eyes of analysts. The current dip could be seen as a reaction to temporary noise.
Instead of trying to time the bottom on news headlines, you might want to see how institutional funds are positioned in the cannabis sector on Edgen Radar. Don't get smoked, babe.